semaglutide vs tirzepatide comparison efficacy side effects When it comes to versus for weight loss, the “best” choice is never one-size-fits-all. At a premium, medically guided level, we compare how each option supports appetite regulation, metabolic response Tirzepatide vs Semaglutide Safety: What
Description
In the pivotal SURMOUNT-1 trial involving adults without diabetes, participants receiving the highest dose (15 mg) lost an average of 20.9% of their body weight over 72 weeks, compared to 3.1% with placebo
Tirzepatide reduces physical hunger but does not address emotional or stress-related eating patterns
Thats why clinical trials report average weight loss of 1521%, and up to 26% when combined with diet and exercise
Injectable tirzepatide is fully approved and widely available
